Impaired brain development in the rat following prenatal exposure to methylazoxymethanol acetate at gestational day 17 and neurotrophin distribution

NeuroReport

Volumn 15, Issue 11, 2004, Pages 1791-1795

  Fiore, Marco ^a   Grace, Anthony A ^b   Korf, Jakob ^a   Stampachiacchiere, Barbara ^c   Aloe, Luigi ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c CNR   (Italy)

Author keywords

BDNF; MAM; NGF; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHYLAZOXYMETHANOL ACETATE; NERVE GROWTH FACTOR; NEUROTROPHIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN DEVELOPMENT; BRAIN LEVEL; CORPUS STRIATUM; ENTORHINAL CORTEX; FEMALE; GESTATIONAL AGE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; PARIETAL LOBE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

AGE FACTORS; ANIMALS; BRAIN; FEMALE; GESTATIONAL AGE; MALE; METHYLAZOXYMETHANOL ACETATE; NERVE GROWTH FACTORS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, INBRED F344; TIME FACTORS;

EID: 4043070802     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000135934.03635.6a     Document Type: Article

References (24)

1. Cattabeni F and Di Luca M. Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol. Physiol Rev 1997; 77:199-215.
2. Talamini LM, Koch T, ter Horst GJ and Korf J. Interference with neurogenesis in the mediotemporal allocortex of the rat; a possible model for schizophrenia. Brain Res 1998; 789:293-306.
3. Fiore M, Talamini L, Angelucci F, Koch T, Aloe L and Korf J. Pharmacologically-induced damage in the entorhinal cortex alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits. Neuropharmacology 1999; 38:857-869.
4. Fiore M, Korf J, Antonelli A, Talamini L and Aloe L. Long-lasting effects of prenatal MAM exposure on water maze response in aged rats: correlation with altered brain development and neurotrophins' expression. Neurotoxicol Teratol 2002; 24:179-191.
5. Sofroniew MV, Howe CL and Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001; 24:1217-1281.
6. Cimino M, Cattabeni F, Di Luca M, Peruzzi G, Andena M, Tirassa P et al. Levels of NGF, p75NGFR and ChAT immunoreactivity in brain of adult and aged microencephalic rats. Neurobiol Aging 1996; 17:137-142.
7. Grace AA and Moore H. Regulation of information flow in the nucleus accumbens: a model for the pathophysiology of schizophrenia. In: Lenzenweger MF and Dworkin RH (eds). Origins and Development of Schizophrenia: Advances in Experimental Psychopathology. Washington, DC: American Psychological Association Press; 1998, pp. 123-157.
8. Moore H, Ghajarnia M, Geyer M, Jentsch JD and Grace AA. Selective disruption of prefrontal and limbic corticostriatal circuits by prenatal exposure to the DNA methylation agent methylazoxymethanol acetate (MAM): anatomical, neurophysiological and behavioral studies. Schizophrenia Res 2001; 49:S1-2,48.
9. Lewin GR and Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996; 19:289-317.
10. Grace AA. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Rev 2000; 31:330-341.
11. Arnold SE. Cellular and molecular neuropathology of the parahippocampal region in schizophrenia. Ann NY Acad Sci 2001; 911:275-292.
12. Connor B and Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 1998; 27:1-39.
13. Thome J, Foley P and Riederer P. Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article. J Neural Transm 1998; 105:85-100.
14. Fiore M, Angelucci F, Aloe L, Iannitelli A and Korf J. Nerve growth factor and brain-derived neurotrophic factor in schizophrenia and depression: findings in humans and in animal models. Curr Neuropharmacol 2003; 1:109-123.
15. Nawa H, Takahashi M and Patterson PH. Cytokine and growth factor involvement in schizophrenia - support for the developmental model. Mol Psych 2000; 5:594-603.
16. Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K et al. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psych 2000; 5:293-300.
17. Egan MF and Weinberger DR. Neurobiology of schizophrenia. Curr Opin Neurobiol 1997; 7:701-707.
18. Kurachi M. Pathogenesis of schizophrenia: Part II. Temporo-frontal two-step hypothesis. Psychiatry Clin Neurosci 2003; 57:9-15.
19. Lipska BK and Weinberger DR. A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus. Neurotox Res 2002; 4:469-475.
20. Alvarez-Buylla A and Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J Neurosci 2002; 22:629-634.
21. Fiore M, Amendola T, Triaca V, Tirassa P, Alleva E and Aloe L. Agonistic encounters in aged male mouse potentiate the expression of endogenous brain NGF and BDNF: possible implication for brain progenitor cells' activation. Eur J Neurosci 2003; 17:1455-1464.
22. Tirassa P, Amendola T, Triaca V, Fiore M and Aloe L. EGF and NGF injected into the brain of old mice enhance BDNF synthesis and increase the number of Ki67 and ChAT-positive cells in the subventricular zone. J Neurosci Res 2003; 72:557-564.
23. Ciaroni S, Cecchini T, Ferri P, Ambrogini P, Cuppini R, Lombardelli G et al. Postnatal development of rat dentate gyrus: effects of methylazoxymethanol administration. Mech Ageing Dev 2002; 123:499-509.
24. Ciaroni S, Cecchini T, Ferri P, Ambrogini P, Cuppini R, Riccio M et al. Impairment of neural precursor proliferation increases survival of cell progeny in the adult rat dentate gyrus. Mech Ageing Dev 2002; 123:1341-1352.